Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance
- PMID: 31229910
- PMCID: PMC6593148
- DOI: 10.1016/j.ijpddr.2019.06.002
Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance
Abstract
Macrocyclic lactone (ML) anthelmintics are the most important class of anthelmintics because of our high dependence on them for the control of nematode parasites and some ectoparasites in livestock, companion animals and in humans. However, resistance to MLs is of increasing concern. Resistance is commonplace throughout the world in nematode parasites of small ruminants and is of increasing concern in horses, cattle, dogs and other animals. It is suspected in Onchocerca volvulus in humans. In most animals, resistance first arose to the avermectins, such as ivermectin (IVM), and subsequently to moxidectin (MOX). Usually when parasite populations are ML-resistant, MOX is more effective than avermectins. MOX may have higher intrinsic potency against some parasites, especially filarial nematodes, than the avermectins. However, it clearly has a significantly different pharmacokinetic profile. It is highly distributed to lipid tissues, less likely to be removed by ABC efflux transporters, is poorly metabolized and has a long half-life. This results in effective concentrations persisting for longer in target hosts. It also has a high safety index. Limited data suggest that anthelmintic resistance may be overcome, at least temporarily, if a high concentration can be maintained at the site of the parasites for a prolonged period of time. Because of the properties of MOX, there are reasonable prospects that strains of parasites that are resistant to avermectins at currently recommended doses will be controlled by MOX if it can be administered at sufficiently high doses and in formulations that enhance its persistence in the host. This review examines the properties of MOX that support this contention and compares them with the properties of other MLs. The case for using MOX to better control ML-resistant parasites is summarised and some outstanding research questions are presented.
Keywords: Avermectin; Ivermectin; Macrocyclic lactone resistance; Milbemycin; Moxidectin; Nematode.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
Moxidectin and the avermectins: Consanguinity but not identity.Int J Parasitol Drugs Drug Resist. 2012 Apr 14;2:134-53. doi: 10.1016/j.ijpddr.2012.04.001. eCollection 2012 Dec. Int J Parasitol Drugs Drug Resist. 2012. PMID: 24533275 Free PMC article. Review.
-
Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?Vet Parasitol. 2005 Oct 24;133(2-3):243-53. doi: 10.1016/j.vetpar.2005.04.008. Epub 2005 Apr 26. Vet Parasitol. 2005. PMID: 16198824 Review.
-
Selection for anthelmintic resistance by macrocyclic lactones in Haemonchus contortus.Int J Parasitol. 1999 Jul;29(7):1101-11. doi: 10.1016/s0020-7519(99)00074-0. Int J Parasitol. 1999. PMID: 10501620
-
Characterization of Haemonchus contortus P-glycoprotein-16 and its interaction with the macrocyclic lactone anthelmintics.Mol Biochem Parasitol. 2015 Nov;204(1):11-5. doi: 10.1016/j.molbiopara.2015.12.001. Epub 2015 Dec 3. Mol Biochem Parasitol. 2015. PMID: 26657092
-
Species composition of larvae cultured after anthelmintic treatment indicates reduced moxidectin susceptibility of immature Cylicocyclus species in horses.Vet Parasitol. 2016 Aug 30;227:77-84. doi: 10.1016/j.vetpar.2016.07.029. Epub 2016 Jul 26. Vet Parasitol. 2016. PMID: 27523942
Cited by
-
Preventive efficacy of six monthly oral doses of Simparica Trio®, Heartgard® Plus, and Interceptor® Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs.Parasit Vectors. 2022 Mar 11;15(1):81. doi: 10.1186/s13071-022-05180-3. Parasit Vectors. 2022. PMID: 35277191 Free PMC article.
-
Most common inappropriate drug usage factors in anthelmintic treatment on sheep farms in Latvia.Vet World. 2022 Feb;15(2):244-251. doi: 10.14202/vetworld.2022.244-251. Epub 2022 Feb 4. Vet World. 2022. PMID: 35400951 Free PMC article.
-
Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains.PLoS Pathog. 2023 Apr 3;19(4):e1011285. doi: 10.1371/journal.ppat.1011285. eCollection 2023 Apr. PLoS Pathog. 2023. PMID: 37011090 Free PMC article.
-
Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in dogs infected with adult heartworms (Dirofilaria immitis).Parasit Vectors. 2025 Apr 14;18(1):138. doi: 10.1186/s13071-025-06732-z. Parasit Vectors. 2025. PMID: 40229900 Free PMC article.
-
Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research.F1000Res. 2024 Sep 11;13:484. doi: 10.12688/f1000research.149854.2. eCollection 2024. F1000Res. 2024. PMID: 39036651 Free PMC article. Review.
References
-
- Al-Azzam S.I., Fleckenstein L., Cheng K.J., Dzimianski M.T., McCall J.W. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs. Biopharm Drug Dispos. 2007;28:431–438. - PubMed
- Al-Azzam, S.I., Fleckenstein, L., Cheng, K.J., Dzimianski, M.T., McCall, J.W., 2007. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs. Biopharm. Drug Dispos. 28, 431-438. - PubMed
-
- AlGusbi S., Krücken J., Ramünke S., von Samson-Himmelstjerna G., Demeler J. Analysis of putative inhibitors of anthelmintic resistance mechanisms in cattle gastrointestinal nematodes. Int. J. Parasitol. 2014;44:647–658. - PubMed
- AlGusbi, S., Krucken, J., Ramunke, S., von Samson-Himmelstjerna, G., Demeler, J. 2014. Analysis of putative inhibitors of anthelmintic resistance mechanisms in cattle gastrointestinal nematodes. Int. J. Parasitol. 44, 647-658. - PubMed
-
- Ali D.N., Hennessy D.R. The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep. J. Vet. Pharmacol. Ther. 1996;19:89–94. - PubMed
- Ali, D.N., Hennessy, D.R. 1996. The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep. J. Vet. Pharmacol. Ther. 19, 89-94. - PubMed
-
- Ali M.M.M., Mukhtar M.M., Baraka O.Z., Homeida M.M.A., Kheir M.M., Mackenzie C.D. Immunocompetence may be important in the effectiveness of Mectizan† (ivermectin) in the treatment of human Onchocerciasis. Acta Trop. 2002;84:49–53. - PubMed
- Ali, M.M.M., Mukhtar, M.M., Baraka, O.Z., Homeida, M.M.A., Kheir, M.M., Mackenzie, C.D. 2002. Immunocompetence may be important in the effectiveness of Mectizan† (ivermectin) in the treatment of human Onchocerciasis. Acta Trop. 84, 49-53. - PubMed
-
- Almeida G.D., Feliz D.C., Heckler R.P., Borges D.G., Onizuka M.K., Tavares L.E., Paiva F., Borges F.A. Ivermectin and moxidectin resistance characterization by larval migration inhibition test in field isolates of Cooperia spp. in beef cattle, Mato Grosso do Sul, Brazil. Vet. Parasitol. 2013;191:59–65. - PubMed
- Almeida, G.D., Feliz, D.C., Heckler, R.P., Borges, D.G., Onizuka, M.K., Tavares, L.E., Paiva, F., Borges, F.A. 2013. Ivermectin and moxidectin resistance characterization by larval migration inhibition test in field isolates of Cooperia spp. in beef cattle, Mato Grosso do Sul, Brazil. Vet. Parasitol. 191, 59-65. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources